Eupraxia Pharmaceuticals Inc
TSX:EPRX

Watchlist Manager
Eupraxia Pharmaceuticals Inc Logo
Eupraxia Pharmaceuticals Inc
TSX:EPRX
Watchlist
Price: 9.11 CAD 4.71% Market Closed
Market Cap: 461.4m CAD

Wall Street
Price Targets

EPRX Price Targets Summary
Eupraxia Pharmaceuticals Inc

Wall Street analysts forecast EPRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EPRX is 12.36 CAD with a low forecast of 9.09 CAD and a high forecast of 16.11 CAD.

Lowest
Price Target
9.09 CAD
0% Downside
Average
Price Target
12.36 CAD
36% Upside
Highest
Price Target
16.11 CAD
77% Upside
Eupraxia Pharmaceuticals Inc Competitors:
Price Targets
IPH
Innate Pharma SA
226% Upside
603087
Gan & Lee Pharmaceuticals
4% Downside
CGON
CG Oncology Inc
87% Upside
LXRX
Lexicon Pharmaceuticals Inc
151% Upside
SLS
Sellas Life Sciences Group Inc
195% Upside
STOK
Stoke Therapeutics Inc
1% Upside
688363
Bloomage Biotechnology Corp Ltd
8% Upside
688278
Xiamen Amoytop Biotech Co Ltd
18% Upside

Revenue
Forecast

Revenue Estimate
Eupraxia Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Eupraxia Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-23%
Average Miss

Net Income
Forecast

Net Income Estimate
Eupraxia Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-48%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EPRX's stock price target?
Price Target
12.36 CAD

According to Wall Street analysts, the average 1-year price target for EPRX is 12.36 CAD with a low forecast of 9.09 CAD and a high forecast of 16.11 CAD.

Back to Top